Physician profile
Loren L Rourke
NPI 1336343235
$4,672.38
in general payments reported to CMS, 2019-2025
23 companies · $1,827 in 2025
The $1,827 reported for 2025 was more than what 79% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,196 · 2020: $18.03 · 2021: $48.27 · 2024: $1,583 · 2025: $1,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,275 · Travel and Lodging: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,275.00 |
| Travel and Lodging | $797.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,325.77 | 2025 | Plasmablade(Tm) |
| Axogen | $1,274.45 | 2020-2025 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Ge Healthcare | $1,053.12 | 2019 | |
| Tempus Ai, INC | $282.18 | 2024-2025 | Xt Cdx |
| Myriad Genetic Laboratories, INC. | $131.27 | 2024 | Myrisk |
| Genentech USA, INC. | $81.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $49.09 | 2024 | Libtayo |
| Allergan, INC. | $48.90 | 2019 | |
| Endomagnetics Ltd | $48.27 | 2021 | |
| Biotissue Holdings INC. | $45.60 | 2025 | |
| Merck Sharp & Dohme LLC | $43.76 | 2024-2025 | Keytruda |
| Janssen Biotech, INC. | $37.60 | 2024-2025 | Rybrevant |
| Lilly USA, LLC | $34.54 | 2024 | Jaypirca, Verzenio |
| Pharmacosmos Therapeutics INC. | $28.44 | 2024 | Monoferric |
| Hologic Sales and Service, LLC | $27.23 | 2025 | Magtrace |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $26.63 | 2024 | Jakafi |
| Novocure INC. | $26.12 | 2025 | Optune Gio |
| Stryker Corporation | $22.87 | 2025 | Spy-Phi System |
| Vertex Pharmaceuticals Incorporated | $21.34 | 2025 | |
| Elucent Medical | $19.10 | 2025 | |
| Puma Biotechnology, INC. | $17.74 | 2024 | |
| Coopersurgical, INC. | $14.63 | 2025 | Onetrac Lx |
| Astrazeneca Pharmaceuticals Lp | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loren Rourke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.